StergiosMoschosMD

PubMed

• Factors associated with radiation necrosis and intracranial control in patients treated with immune checkpoint inhibitors and stereotactic radiotherapy.
  Jacob Hall, Kevin Lui, Xianming Tan, John Shumway, Frances Collichio, Stergios Moschos, Soma Sengupta, Rekha Chaudhary, Carolyn Quinsey, Sivakumar Jaikumar, Jonathan F...> ;Radiotherapy and Oncology. 2023 Dec 1
• 5 citations
  Multi-organ landscape of therapy-resistant melanoma.
  Sixue Liu, Prashanthi Dharanipragada, Shirley H Lomeli, Yan Wang, Xiao Zhang, Zhentao Yang, Raymond J Lim, Camelia Dumitras, Philip O Scumpia, Steve M Dubinett, Gatien...> ;Nature Medicine. 2023 May 1
• 3 citations
  Development of [F]F-5-OMe-Tryptophans through Photoredox Radiofluorination: A New Method to Access Tryptophan-Based PET Agents.
  Xuedan Wu, Xinrui Ma, Yaofeng Zhong, Wei Chen, Muyun Xu, He Zhang, Li Wang, Xianshuang Tu, Zhaoguo Han, Weiling Zhao, Zhanhong Wu, Stergios J Moschos, Zibo Li> ;Journal of Medicinal Chemistry. 2023 Mar 9
• 15 citations
  Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in Melanoma.
  Prashanthi Dharanipragada, Xiao Zhang, Sixue Liu, Shirley H Lomeli, Aayoung Hong, Yan Wang, Zhentao Yang, Kara Z Lo, Agustin Vega-Crespo, Antoni Ribas, Stergios J Mosc...> ;Cancer Discovery. 2023 Apr 3
• 1 citations
  Increased tryptophan, but not increased glucose metabolism, predict resistance of pembrolizumab in stage III/IV melanoma.
  Jorge D Oldan, Benjamin C Giglio, Eric Smith, Weiling Zhao, Deeanna M Bouchard, Marija Ivanovic, Yueh Z Lee, Frances A Collichio, Michael O Meyers, Diana E Wallack, Am...> ;Oncoimmunology. 2023 Jan 1
• 3 citations
  InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma.
  Irene Orlow, Keimya D Sadeghi, Sharon N Edmiston, Jessica M Kenney, Cecilia Lezcano, James S Wilmott, Anne E Cust, Richard A Scolyer, Graham J Mann, Tim K Lee, Hazel B...> ;Plos One. 2023 Jan 1
• 3 citations
  Theragnostic significance of tumor-infiltrating lymphocytes and Ki67 in BRAFV600-mutant metastatic melanoma (BRIM-3 trial).
  Paul B Googe, Stamatios Theocharis, Alexandros Pergaris, Haocheng Li, Yibing Yan, Edward F McKenna Jr, Stergios J Moschos> ;Current Problems in Cancer. 2022 Jun 1
• 4 citations
  Targeting wild-type TP53 using AMG 232 in combination with MAPK inhibition in Metastatic Melanoma; a phase 1 study.
  Stergios J Moschos, Shahneen Sandhu, Karl D Lewis, Ryan J Sullivan, Igor Puzanov, Douglas B Johnson, Haby A Henary, Hansen Wong, Vijay V Upreti, Georgina V Long, Keith...> ;Investigational New Drugs. 2022 Oct 1
• War against NRAS-Mutant Melanoma Using Targeted Therapies Remains Challenging.
  Stergios J Moschos> ;Clinical Cancer Research. 2022 Jul 15
• 2 citations
  Melanoma Brain Metastases: An Update on the Use of Immune Checkpoint Inhibitors and Molecularly Targeted Agents.
  Stergios J Moschos> ;American Journal of Clinical Dermatology. 2022 Jul 1
• 3 citations
  The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma.
  Georgia Sofia Karachaliou, Rached Alkallas, Sarah B Carroll, Chongshan Caressi, Danny Zakria, Nirali M Patel, Dimitri G Trembath, Jennifer A Ezzell, Guillaume J Pegna,...> ;BMC Cancer. 2022 Jan 5
• 97 citations
  Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label...
  Hussein Abdul-Hassan Tawbi, Peter A. Forsyth, F. Stephen Hodi, Alain Algazi, Omid Hamid, Christopher D. Lao, Stergios J. Moschos, Michael B. Atkins, Karl D. Lewis, Mic...> ;The Lancet. Oncology. 2021 Nov 10
• 8 citations
  Multiregional genetic evolution of metastatic uveal melanoma
  Daniel A. Rodriguez, Jessica Yang, Michael A. Durante, Alexander N. Shoushtari, Stergios J. Moschos, Kazimierz O. Wrzeszczynski, J. William Harbour, Richard D. Carvajal> ;NPJ Genomic Medicine. 2021 Aug 16
• 54 citations
  Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204).
  Hussein Abdul-Hassan Tawbi, Peter A. Forsyth, F. Stephen Hodi, Christopher D. Lao, Stergios J. Moschos, Omid Hamid, Michael B. Atkins, Karl D. Lewis, Reena Thomas, Joh...> ;Neuro-Oncology. 2021 Apr 21
• 2 citations
  Melanoma-specific expression of the tumor suppressor proteins p16 and PTEN is a favorable prognostic factor in established melanoma brain metastases.
  Dimitri G. Trembath, Anastasia Ivanova, Michal T. Krauze, John M. Kirkwood, Nana Nikolaishvilli-Feinberg, Stergios J. Moschos> ;Melanoma Research. 2021 Jun 1
• 6 citations
  Targeting the IL-2 inducible kinase in melanoma; a phase 2 study of ibrutinib in systemic treatment-refractory distant metastatic cutaneous melanoma: preclinical ratio...
  Stergios J. Moschos, Zeynep Eroglu, Nikhil I. Khushalani, Kari Kendra, George Ansstas, Gino K. In, Peng Wang, Glenn Liu, Frances A. Collichio, Paul B. Googe, Craig C. ...> ;Melanoma Research. 2021 Apr 1
• 15 citations
  Brain Tumor Microenvironment and Angiogenesis in Melanoma Brain Metastases
  Dimitri G. Trembath, Davis Eric, Shanti Rao, Evan Bradler, Angelica F. Saada, Bentley R. Midkiff, Anna C. Snavely, Matthew G. Ewend, Frances A. Collichio, Carrie B. Le...> ;Frontiers in Oncology. 2021 Jan 21
• 7 citations
  Immune Checkpoint Markers in Superficial Angiosarcomas: PD-L1, PD-1, CD8, LAG-3, and Tumor-Infiltrating Lymphocytes.
  Paul B. Googe, Kyle Flores, Francie Jenkins, Bradley G. Merritt, Stergios J. Moschos, Juneko E. Grilley-Olson> ;The American Journal of Dermatopathology. 2021 Aug 1
• 8 citations
  Chemotherapy Following PD-1 Inhibitor Blockade in Patients with Unresectable Stage III/Stage IV Metastatic Melanoma: A Single Academic Institution Experience.
  Georgia-Sofia Karachaliou, Fatih Ayvali, Frances A. Collichio, Carrie B. Lee, Anastasia Ivanova, David W. Ollila, Stergios J. Moschos> ;Oncology. 2020 Jan 1
• 19 citations
  Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis
  Kathleen Conway, Sharon N. Edmiston, Joel S. Parker, Pei Fen Kuan, Yi-Hsuan Tsai, Pamela A. Groben, Daniel C. Zedek, Glynis Scott, Eloise Parrish, Honglin Hao, Michell...> ;The Journal of Investigative Dermatology. 2019 Jun 1
• 69 citations
  Prognostic value of B cells in cutaneous melanoma
  Sara R. Selitsky, Lisle E. Mose, Christof C. Smith, Shengjie Chai, Katherine A. Hoadley, Dirk P. Dittmer, Stergios J. Moschos, Joel S. Parker, Benjamin G. Vincent> ;Genome Medicine. 2019 May 28
• 31 citations
  Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities.
  Zeynep Eroglu, Sheri L Holmen, Qing Chen, Nikhil I Khushalani, Ravi Amaravadi, Reena Thomas, Kamran A Ahmed, Hussein Tawbi, Sunandana Chandra, Joseph Markowitz, Inna S...> ;Pigment Cell & Melanoma Research. 2019 May 1
• 14 citations
  Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases.
  Maria J. Sambade, Grace Prince, Allison M. Deal, Dimitri G. Trembath, Megan Jean McKee, Amy Garrett, Kevin Keith, Juanita Ramirez, Bentley R. Midkiff, Kimberly L. Blac...> ;Breast Cancer Research and Treatment. 2019 Apr 23
• 774 citations
  Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.
  Hussein Abdul-Hassan Tawbi, Peter A. Forsyth, Alain Algazi, Omid Hamid, F. Stephen Hodi, Stergios J. Moschos, Nikhil I. Khushalani, Karl D. Lewis, Christopher D. Lao, ...> ;The New England Journal of Medicine. 2018 Aug 22
• 90 citations
  Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors.
  Stergios J. Moschos, Ryan J. Sullivan, Wen-Jen Hwu, Ramesh K. Ramanathan, Alex A. Adjei, Peter C.C. Fong, Ronnie Shapira-Frommer, Hussein Tawbi, Joseph Rubino, Thomas ...> ;JCI Insight. 2018 Feb 22
• Join now to see all